Current Neuro-Oncology

Volume 28 Number 23
20 August 2026

Home > Publications > Current Neuro-Oncology > Volume 28, Year 2026 > Number 23, 20 August

Drijver AJ, Butterbrod E, Hertler C, Frances SM, Reifenberger G, Felsberg J, Gorlia T, van den Dobbelsteen EMC, de Boer N, Rudà R, Pellerino A, Clarke J, Kumar-Wessel K, Tabouret E, Schnell O, Wick W, Darlix A, Lombardi G, van den Bent M, Ducray F, Ronellenfitsch MW, Hau P, Thon N, Preusser M, Le Rhun E, Wen PY, Reijneveld JC, Weller M, Klein M; EORTC Brain Tumor Group.
Neurocognitive functioning in long-term survivors of glioblastoma, IDH-wildtype and astrocytoma, IDH-mutant, CNS WHO grade 4: A report from EORTC 1419 (ETERNITY).
Eur J Cancer. 2026 Aug 12;246:116985. doi: 10.1016/j.ejca.2026.116985. PMID: 42607618. ˍ

Tsuzuki S, Muragaki Y, Nitta M, Masui K, Komori T, Saito T, Maruyama T, Koriyama S, Ro B, Kawamata T.
Clinical and molecular characteristics of thalamic gliomas in adults: prognostic impact of TERT promoter mutation.
Neurosurg Rev. 2026 Aug 14;49(1):523. doi: 10.1007/s10143-026-04447-y. PMID: 42595830. ˍ

Leuthardt EC, Chiang V, Hadjipanayis CG, Landazuri P, Placantonakis DG, Abram SR, Sun DA, Smith KA, Mohammadi AM, Chen CC, Williams BJ, Piccioni DE, Hodges TR, Sloan AE, Lega B, Rodriguez A, Lacroix M, Panov F, Borghei-Razavi H, Baumgartner J, Abel TJ, Bandt K, Smyth MD, Rao G, Fecci PE, Laxton AW, Tatter SB, Kim AH, Prabhu SS.
Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.
J Clin Oncol. 2026 Aug 17:JCO2502604. doi: 10.1200/JCO-25-02604. PMID: 42607280. ˍ

Carniel CF, Souza BC, Leite HF, Zangirolami-Raimundo J, Raimundo RD.
Therapeutic Exercise Protocol During Hospitalization in Pediatric Oncohematological Patients: Randomized Clinical Trial.
Physiother Res Int. 2026 Aug 18;31(4):e70324. doi: 10.1002/pri.70324. PMID: 42610644. Trial registration ID: RBR-8sxnfyd. ˍ

Dassi N, Figueiredo MLS, Gamba FT, da Costa MDS, Dos Santos Torquato AC, Rodrigues JB, de Souza Filho RM, Cavalheiro S, Dastoli PA, Silva FA, Moraes CVB, de Toledo SRC, Da Silva NS, Chen MJ, Cappellano AM.
Reirradiation for diffuse intrinsic pontine glioma in an upper middle-income country: does full dose improve outcomes?
Childs Nerv Syst. 2026 Aug 20;42(1):340. doi: 10.1007/s00381-026-07390-x. PMID: 42622719. ˍ

Iglesias S, Becerra V, Miranda P, Márquez T, Galbarriatu L, Munarriz PM, Gimenez J, Saceda J, Rius F, Hinojosa J.
Clinical, molecular, and surgical predictors of outcome in non-DIPG pediatric diffuse midline gliomas: A collaborative retrospective analysis.
Childs Nerv Syst. 2026 Aug 20;42(1):341. doi: 10.1007/s00381-026-07432-4. PMID: 42622932˰ ˍ

Nayab A, Mughal N, Angez M, Xing S, Burma AM, Balla H, Kizilbash SH, Yang X, Maqbool MA, Arain F, Hussain A, Amir S, Singh D, Karmali A, Somani S, Patel TR, Patel A, Hatanpaa KJ, Youssef M, Shaikh N, Ye C, Zhao D, Burma S, Sarkaria JN, Majd NK, Saleh M, Charest A, Miller CR, Nabors LB, Kataru MS, Tolbert CE, Jimenez F, Enam SA, Habib AA, Guo G.
EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma.
Sci Transl Med. 2026 Jul 8;18(857):eadx8398. doi: 10.1126/scitranslmed.adx8398. PMID: 42418561˰ ˍ
COMMENT
Yu X, Wu R, Cheng SY. Sequential EGFR inhibition sensitizes glioblastoma to temozolomide.
Trends Pharmacol Sci. 2026 Aug 17:S0165-6147(26)00197-5. doi: 10.1016/j.tips.2026.07.010. PMID: 42608284. ˍ

Dougherty JM, Kowalchuk RO, Ebner DK, Merrell KW, Johnson-Tesch BA, Morris JM, Harmsen WS, Breen WG, Shiraishi S, Iott MJ, Stish BJ, Owen D, Kruse JJ, Beltran CJ, Mikula AL, Brown PD, Laack NN, Foote RL, Olivier KR, Mullikin TC, Park SS.
Early Clinical Outcomes and Local Control Following Spine Stereotactic Proton Ablative Radiation Therapy.
Adv Radiat Oncol. 2026 Jul 11;11(10):102141. doi: 10.1016/j.adro.2026.102141. PMID: 42620294. ˍ

Gan L, Ma Y.
Low-dose temozolomide combined with valproic acid in the treatment of an elderly patient with MGMT-methylated glioblastoma and multiple comorbidities: a case report.
Front Oncol. 2026 Jul 30;16:1853109. doi: 10.3389/fonc.2026.1853109. PMID: 42597355. ˍ

Bittner C, Ganapathy S, Baccon J.
Educational Case: Medulloblastoma.
Acad Pathol. 2026 Jul 31;13(4):100283. doi: 10.1016/j.acpath.2026.100283. PMID: 42576978. ˍ

Ruggiero A, Talloa D, Romano A, Maurizi P, Mastrangelo S, Verdolotti T, Mariani S, Chiesa S, di Bonaventura R, Massimi L, Tamburrini G, Albanese A, Attinà G.
Age-Dependent Toxicity Patterns in Medulloblastoma: A Comparative Analysis of Treatment-Related Adverse Events Between Pediatric and Adult Populations.
J Clin Med. 2026 Aug 3;15(15):6023. doi: 10.3390/jcm15156023. PMID: 42590125. ˍ

Rizzaro MD, Fanizzi C, Fiore G, Remore LG, Vecchio GD, Scagliotti E, Pratelli G, Borsa S, Navone SE, Bertorelli I, Sironi LE, Roda G, Marfia G, Caroli M, Locatelli M.
Reduced-Dose Regorafenib for Recurrent Glioblastoma: A Safety and Outcome Analysis.
Cancers (Basel). 2026 Aug 6;18(15):2522. doi: 10.3390/cancers18152522. PMID: 42588736. ˍ

Katzendobler S, Kuschel L, Zieger N, Thiele F, Schmutzer-Sondergeld M, Jankovic D, Stürzl R, Harter PN, Stahl R, Kalasauskas D, Jakola AS, Albert NL, Le Rhun E, Weller M, Ringel F, Weller J.
Patterns of radiological response to procarbazine and CCNU polychemotherapy in patients with oligodendroglioma.
Neurooncol Adv. 2026 Aug 6;8(1):vdag184. doi: 10.1093/noajnl/vdag184. PMID: 42603070. ˍ

Fong V, Ly M, Erickson AW, Abeysundara N, Hendrikse L, Ommeren RV, Balin P, Mishra J, Livingston B, Skowron P, Sirbu O, Mankahla N, Zhang J, Richman C, Suarez R, Huang N, Wang H, Qin L, Douglas T, Pallotta J, Mak E, Kumar SA, Kaushik AK, Vu H, Zacharias L, Veerasammy K, Chen YX, Ocsenas O, Voisin V, Taj F, Koubourli D, Dzieciol V, Xu L, Harvey M, Fan JJ, Przelicki D, Yeh A, Kharas K, Rasnitsyn A, Wang E, Ong W, Jubenville T, Yang Q, Huang X, Ayrault O, Wechsler-Reya R, Egan SE, Largaespada D, DeBerardinis RJ, Ye H, Abzalimov R, Stein L, Ellison DW, Bader G, Lucas CH, Saulnier O, Shih D, Reimand J, Daniels C, Singh S, Agnihotri S, Rich JN, Ramaswamy V, Taylor MD, Wu X.
Medulloblastoma Forms Symbiotic Metabolic Partnerships with Macrophages to Establish Leptomeningeal Metastases.
bioRxiv [Preprint]. 2026 Aug 9:2026.07.26.740417. doi: 10.64898/2026.07.26.740417. PMID: 42619780. ˍ